Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline MyelofibrosisBusiness Wire • 08/22/22
Geron Corporation's (GERN) CEO Dr. John Scarlett on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/12/22
All You Need to Know About Geron (GERN) Rating Upgrade to Strong BuyZacks Investment Research • 08/04/22
Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual ConferenceBusiness Wire • 08/03/22
Geron Corporation Announces Appointment of Faye Feller, M.D. to Chief Medical Officer and Transition of Aleksandra Rizo, M.D.Business Wire • 06/15/22
Geron Corporation (GERN) CEO John Scarlett on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/09/22